AQEMIA Raises $38 Million with Cathay Innovation Lead
Deal News | Dec 10, 2024 | Goodwin
AQEMIA, a pioneering company in drug discovery, has successfully raised $38 million in its latest financing round, elevating its total capital to over $100 million. The investment round was spearheaded by Cathay Innovation and included participation from established investors like Wendel, Bpifrance Large Venture, Eurazeo, and Elaia. Utilizing a cutting-edge platform that melds quantum-inspired physics with generative AI, AQEMIA is revolutionizing the speed and efficacy of drug candidate discovery. The newly acquired funds are strategically allocated towards the company's development goals, particularly in preparing for clinical trials and enhancing its platform for therapeutic molecule design. Legal advisory for this round was provided by Goodwin, with Xavier Leroux and Augustin Piqueras spearheading the team's efforts. Goodwin has been closely collaborating with AQEMIA across multiple funding rounds since 2019.
Sectors
- Biotechnology
- Artificial Intelligence
- Venture Capital
Geography
- France – AQEMIA is based in Paris, and the advisory team from Goodwin is also part of the Paris Technology & Life Sciences sector.
Industry
- Biotechnology – AQEMIA operates within the biotechnology sector, focusing on drug discovery through innovative technologies.
- Artificial Intelligence – The company uses generative AI combined with quantum-inspired physics for therapeutic molecule design, a key feature of the AI industry.
- Venture Capital – Cathay Innovation and other investors are prominent venture capital firms participating in the funding round.
Financials
- $38 million – Amount raised by AQEMIA in the latest financing round.
- $100 million – Total cumulative funding raised by AQEMIA since inception.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| AQEMIA | Target Company | Company | A biotechnology company using AI and quantum-inspired physics for drug discovery. |
| Cathay Innovation | Lead Investor | Company | A venture capital firm that led AQEMIA's financing round. |
| Wendel | Investor | Company | A historical investor in AQEMIA. |
| Bpifrance Large Venture | Investor | Company | A historical investor in AQEMIA. |
| Eurazeo | Investor | Company | A historical investor in AQEMIA. |
| Elaia | Investor | Company | A historical investor in AQEMIA. |
| Goodwin | Legal Advisor | Company | The law firm advising AQEMIA on the financing round. |
| Xavier Leroux | Legal Lead | Person | Led Goodwin's legal team for AQEMIA's funding round. |
| Augustin Piqueras | Corporate Aspects | Person | Involved in corporate aspects for Goodwin's advisory role. |